These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10553211)

  • 1. Understanding external controls over the commercial introduction of engineered human tissues. Assessing regulatory and liability issues.
    Smith DS
    Clin Plast Surg; 1999 Oct; 26(4):537-48, vii. PubMed ID: 10553211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of FDA reform.
    Trunzo J
    Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA user fee and Modernisation Act.
    Donawa M
    Med Device Technol; 2002 Dec; 13(10):27-9. PubMed ID: 12575526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current regulatory and legal considerations for follow-on biologics.
    Kingham RF; Lietzan E
    Clin Pharmacol Ther; 2008 Nov; 84(5):633-5. PubMed ID: 18716615
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory perspectives on pharmacogenomics: a review of the literature on key issues faced by the United States Food and Drug Administration.
    Phillips KA; Van Bebber SL
    Med Care Res Rev; 2006 Jun; 63(3):301-26. PubMed ID: 16651395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Human Genome Project in the United States: a perspective on the commercial, ethical, legislative and health care issues.
    Mackler BF; Barach M
    J Int Bioethique; 1991; 2(3):149-57. PubMed ID: 11654898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA regulatory review and approval processes: a Delphi inquiry.
    Dziurzynski B
    Food Drug Law J; 1996; 51(1):143-53. PubMed ID: 11794347
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulating recombinant DNA biologics.
    Crouch ML
    Arzneimittelforschung; 1988 Jul; 38(7):947-9. PubMed ID: 3207440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal cell transplantation: FDA meeting July 13 and 14. Food and Drug Administration.
    James JS
    AIDS Treat News; 1995 Jul; (no 226):7-8. PubMed ID: 11362616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of regulating biotechnology-derived animals in Canada: animal health and food safety considerations.
    Kochhar HP; Evans BR
    Theriogenology; 2007 Jan; 67(1):188-97. PubMed ID: 17097725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current good tissue practice for human cell, tissue, and cellular and tissue-based product establishments; inspection and enforcement. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Nov; 69(226):68611-88. PubMed ID: 15562555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to the Food and Drug Administration (FDA) regulatory process.
    Hackett JL; Gutman SI
    J Proteome Res; 2005; 4(4):1110-3. PubMed ID: 16083260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of FDA regulation of human cellular and tissue-based products.
    Wells MA
    Food Drug Law J; 1997; 52(4):401-8. PubMed ID: 10346672
    [No Abstract]   [Full Text] [Related]  

  • 15. The ability of current biologics law to accommodate emerging technologies.
    Carter MJ
    Food Drug Law J; 1996; 51(3):375-80. PubMed ID: 11797714
    [No Abstract]   [Full Text] [Related]  

  • 16. Current regulatory issues in cell and tissue therapy.
    Burger SR
    Cytotherapy; 2003; 5(4):289-98. PubMed ID: 12944234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of biotechnology products in the global pharmaceutical market: the case of the European community and the United States.
    Hakim Z; Kucukarslan S
    Clin Ther; 1993; 15(2):442-58; discussion 432. PubMed ID: 8519050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do regulatory agencies ensure the release of a safe medical device?
    Haggar B
    Clin Perform Qual Health Care; 1999; 7(2):100-3. PubMed ID: 10747561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bringing safe and effective cell therapies to the bedside.
    Preti RA
    Nat Biotechnol; 2005 Jul; 23(7):801-4. PubMed ID: 16003360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.